A lot of interest and accumulation by other players in the industry suggest this is the bottom and MRM is oversold. This will be the next BKN in my view.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025